1	SAME-AS	\N	1	2016-07-07 00:00:00	\N	\N	0	0	\N	\N	\N	35543629-7d8c-11e1-909d-c80aa9edcf4e
2	NARROWER-THAN	\N	1	2016-07-07 00:00:00	\N	\N	0	0	\N	\N	\N	43ac5109-7d8c-11e1-909d-c80aa9edcf4e
3	BROADER-THAN	\N	1	2016-07-07 00:00:00	\N	\N	0	0	\N	\N	\N	4b9d9421-7d8c-11e1-909d-c80aa9edcf4e
4	Associated finding	\N	1	2016-07-07 00:00:00	\N	\N	0	0	\N	\N	\N	55e02065-7d8c-11e1-909d-c80aa9edcf4e
5	Associated morphology	\N	1	2016-07-07 00:00:00	\N	\N	0	0	\N	\N	\N	605f4a61-7d8c-11e1-909d-c80aa9edcf4e
6	Associated procedure	\N	1	2016-07-07 00:00:00	\N	\N	0	0	\N	\N	\N	6eb1bfce-7d8c-11e1-909d-c80aa9edcf4e
7	Associated with	\N	1	2016-07-07 00:00:00	\N	\N	0	0	\N	\N	\N	781bdc8f-7d8c-11e1-909d-c80aa9edcf4e
8	Causative agent	\N	1	2016-07-07 00:00:00	\N	\N	0	0	\N	\N	\N	808f9e19-7d8c-11e1-909d-c80aa9edcf4e
9	Finding site	\N	1	2016-07-07 00:00:00	\N	\N	0	0	\N	\N	\N	889c3013-7d8c-11e1-909d-c80aa9edcf4e
10	Has specimen	\N	1	2016-07-07 00:00:00	\N	\N	0	0	\N	\N	\N	929600b9-7d8c-11e1-909d-c80aa9edcf4e
11	Laterality	\N	1	2016-07-07 00:00:00	\N	\N	0	0	\N	\N	\N	999c6fc0-7d8c-11e1-909d-c80aa9edcf4e
12	Severity	\N	1	2016-07-07 00:00:00	\N	\N	0	0	\N	\N	\N	a0e52281-7d8c-11e1-909d-c80aa9edcf4e
13	Access	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	f9e90b29-7d8c-11e1-909d-c80aa9edcf4e
14	After	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	01b60e29-7d8d-11e1-909d-c80aa9edcf4e
15	Clinical course	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	5f7c3702-7d8d-11e1-909d-c80aa9edcf4e
16	Component	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	67debecc-7d8d-11e1-909d-c80aa9edcf4e
17	Direct device	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	718c00da-7d8d-11e1-909d-c80aa9edcf4e
18	Direct morphology	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	7b9509cb-7d8d-11e1-909d-c80aa9edcf4e
19	Direct substance	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	82bb495d-7d8d-11e1-909d-c80aa9edcf4e
20	Due to	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	8b77f7d3-7d8d-11e1-909d-c80aa9edcf4e
21	Episodicity	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	94a81179-7d8d-11e1-909d-c80aa9edcf4e
22	Finding context	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	9d23c22e-7d8d-11e1-909d-c80aa9edcf4e
23	Finding informer	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	a4524368-7d8d-11e1-909d-c80aa9edcf4e
24	Finding method	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	af089254-7d8d-11e1-909d-c80aa9edcf4e
25	Has active ingredient	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	b65aa605-7d8d-11e1-909d-c80aa9edcf4e
26	Has definitional manifestation	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	c2b7b2fa-7d8d-11e1-909d-c80aa9edcf4
27	Has dose form	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	cc3878e6-7d8d-11e1-909d-c80aa9edcf4e
28	Has focus	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	d67c5840-7d8d-11e1-909d-c80aa9edcf4e
29	Has intent	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	de2fb2c5-7d8d-11e1-909d-c80aa9edcf4e
30	Has interpretation	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	e758838b-7d8d-11e1-909d-c80aa9edcf4e
31	Indirect device	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	ee63c142-7d8d-11e1-909d-c80aa9edcf4e
32	Indirect morphology	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	f4f36681-7d8d-11e1-909d-c80aa9edcf4e
33	Interprets	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	fc7f5fed-7d8d-11e1-909d-c80aa9edcf4e
34	Measurement method	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	06b11d79-7d8e-11e1-909d-c80aa9edcf4e
35	Method	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	0efb4753-7d8e-11e1-909d-c80aa9edcf4e
36	Occurrence	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	16e7b617-7d8e-11e1-909d-c80aa9edcf4e
37	Part of	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	1e82007b-7d8e-11e1-909d-c80aa9edcf4e
38	Pathological process	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	2969915e-7d8e-11e1-909d-c80aa9edcf4e
39	Priority	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	32d57796-7d8e-11e1-909d-c80aa9edcf4e
40	Procedure context	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	3f11904c-7d8e-11e1-909d-c80aa9edcf4e
41	Procedure device	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	468c4aa3-7d8e-11e1-909d-c80aa9edcf4e
42	Procedure morphology	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	5383e889-7d8e-11e1-909d-c80aa9edcf4e
43	Procedure site	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	5ad2655d-7d8e-11e1-909d-c80aa9edcf4e
44	Procedure site - Direct	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	66085196-7d8e-11e1-909d-c80aa9edcf4e
45	Procedure site - Indirect	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	7080e843-7d8e-11e1-909d-c80aa9edcf4e
46	Property	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	76bfb796-7d8e-11e1-909d-c80aa9edcf4e
47	Recipient category	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	7e7d00e4-7d8e-11e1-909d-c80aa9edcf4e
48	Revision status	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	851e14c1-7d8e-11e1-909d-c80aa9edcf4e
49	Route of administration	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	8ee5b13d-7d8e-11e1-909d-c80aa9edcf4e
50	Scale type	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	986acf48-7d8e-11e1-909d-c80aa9edcf4e
51	Specimen procedure	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	a6937642-7d8e-11e1-909d-c80aa9edcf4e
52	Specimen source identity	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	b1d6941e-7d8e-11e1-909d-c80aa9edcf4e
53	Specimen source morphology	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	b7c793c1-7d8e-11e1-909d-c80aa9edcf4e
54	Specimen source topography	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	be9f9eb8-7d8e-11e1-909d-c80aa9edcf4e
55	Specimen substance	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	c8f2bacb-7d8e-11e1-909d-c80aa9edcf4e
56	Subject of information	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	d0664c4f-7d8e-11e1-909d-c80aa9edcf4e
57	Subject relationship context	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	dace9d13-7d8e-11e1-909d-c80aa9edcf4e
58	Surgical approach	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	e3cd666d-7d8e-11e1-909d-c80aa9edcf4e
59	Temporal context	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	ed96447d-7d8e-11e1-909d-c80aa9edcf4e
60	Time aspect	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	f415bcce-7d8e-11e1-909d-c80aa9edcf4e
61	Using access device	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	fa9538a9-7d8e-11e1-909d-c80aa9edcf4e
62	Using device	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	06588655-7d8f-11e1-909d-c80aa9edcf4e
63	Using energy	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	0c2ae0bc-7d8f-11e1-909d-c80aa9edcf4e
64	Using substance	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	13d2c607-7d8f-11e1-909d-c80aa9edcf4e
65	IS A	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	1ce7a784-7d8f-11e1-909d-c80aa9edcf4e
66	MAY BE A	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	267812a3-7d8f-11e1-909d-c80aa9edcf4e
67	MOVED FROM	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	2de3168e-7d8f-11e1-909d-c80aa9edcf4e
68	MOVED TO	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	32f0fd99-7d8f-11e1-909d-c80aa9edcf4e
69	REPLACED BY	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	3b3b9a7d-7d8f-11e1-909d-c80aa9edcf4e
70	WAS A	\N	1	2016-07-07 00:00:00	\N	\N	1	0	\N	\N	\N	41a034da-7d8f-11e1-909d-c80aa9edcf4e
